News
This twice-a-year shot to prevent HIV could stop transmission — if people can get it
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.S. and abroad will get access to the powerful new option.
The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding ...
And more pharma news updates from Pharmalittle.
The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...
Gilead Sciences Inc. (NASDAQ:GILD) is one of the 12 best healthcare stocks to buy now. Nevertheless, the company suffered a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback